Population
103 acute myocardial infarction patients and 95 healthy controls; in vitro ox-LDL-induced human coronary…
Comparison
Assessment of miR-146b-5p expression levels… vs Healthy controls; ox-LDL without inhibition
Design
Case-control
Key result
Upregulated miR-146b-5p expression was observed in 103 AMI patients compared to 95 healthy controls, demonstrating diagnostic value and predicting poor prognosis.
Authors
Loading...
May aid AMI diagnosis if replicated; first human data extends miR-146b-5p observations to acute coronary syndromes.
Case-Control (n=198)
miR-146b-5p is upregulated in AMI, correlates with disease severity and poor prognosis, and promotes endothelial injury by targeting PRKAR2A, suggesting it as a potential biomarker and therapeutic target.
Wu et al. (2026) conducted a case-control in Acute myocardial infarction (n=198). miR-146b-5p expression vs. Healthy controls was evaluated on Diagnosis and prognosis of acute myocardial infarction. Upregulated miR-146b-5p expression was observed in 103 AMI patients compared to 95 healthy controls, demonstrating diagnostic value and predicting poor prognosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: